We demonstrate that endothelial EphB4 overexpression leads to maintenance of pericyte–endothelial interactions despite effective anti-VEGF and anti-PDGF treatment leading to resistant glioma vasculature in a subcutaneous SF126 glioma model. The gene discussed is EPHB4; the disease is central nervous system cancer.